Cory Berkland - Publications

Bioengineering University of Kansas, Lawrence, KS, United States 
Biomedical Engineering, Pharmaceutical Chemistry, Nanotechnology

127 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Ruiz SI, El-Gendy N, Bowen LE, Berkland C, Bailey MM. Formulation and Characterization of Nanocluster Ceftazidime for the Treatment of Acute Pulmonary Melioidosis. Journal of Pharmaceutical Sciences. PMID 27639659 DOI: 10.1016/j.xphs.2016.07.029  0.68
2016 Beck EC, Barragan M, Libeer TB, Kieweg SL, Converse GL, Hopkins RA, Berkland C, Detamore MS. Chondroinduction from Naturally-Derived Cartilage Matrix: A Comparison Between Devitalized and Decellularized Cartilage Encapsulated in Hydrogel Pastes. Tissue Engineering. Part A. PMID 27001140 DOI: 10.1089/ten.TEA.2015.0546  0.68
2016 Antunez LR, Livingston A, Berkland C, Dhar P. Physiochemical properties of aluminum adjuvants elicit differing reorganization of phospholipid domains in model membranes. Molecular Pharmaceutics. PMID 26998680 DOI: 10.1021/acs.molpharmaceut.6b00111  0.68
2016 Alhakamy NA, Dhar P, Berkland CJ. Charge Type, Charge Spacing, and Hydrophobicity of Arginine-Rich Cell Penetrating Peptides Dictate Gene Transfection. Molecular Pharmaceutics. PMID 26878305 DOI: 10.1021/acs.molpharmaceut.5b00871  0.68
2016 Hartwell BL, Martinez-Becerra F, Chen J, Shinogle HE, Sarnowski M, Moore DS, Berkland C. Antigen-Specific Binding of Multivalent Soluble Antigen Arrays Induces Receptor Clustering and Impedes B Cell Receptor Mediated Signaling. Biomacromolecules. PMID 26771518 DOI: 10.1021/acs.biomac.5b01097  0.68
2016 Alhakamy NA, Ishiguro S, Uppalapati D, Berkland CJ, Tamura M. AT2R Gene Delivered by Condensed Polylysine Complexes Attenuates Lewis Lung Carcinoma after Intravenous Injection or Intratracheal Spray. Molecular Cancer Therapeutics. 15: 209-18. PMID 26637367 DOI: 10.1158/1535-7163.MCT-15-0448  0.68
2015 Hartwell BL, Smalter Hall A, Swafford D, Sullivan BP, Garza A, Sestak JO, Northrup L, Berkland C. Molecular Dynamics of Multivalent Soluble Antigen Arrays Support Two-Signal Codelivery Mechanism in Treatment of Experimental Autoimmune Encephalomyelitis. Molecular Pharmaceutics. PMID 26636828 DOI: 10.1021/acs.molpharmaceut.5b00825  0.68
2015 Northrup L, Christopher MA, Sullivan BP, Berkland C. Combining antigen and immunomodulators: Emerging trends in antigen-specific immunotherapy for autoimmunity. Advanced Drug Delivery Reviews. PMID 26546466 DOI: 10.1016/j.addr.2015.10.020  0.68
2015 Qian J, Sullivan BP, Berkland C. pH-Responsive Micelle Sequestrant Polymers Inhibit Fat Absorption. Biomacromolecules. PMID 26133544 DOI: 10.1021/acs.biomac.5b00560  0.68
2015 Sullivan BP, El-Gendy N, Kuehl C, Berkland C. Pulmonary Delivery of Vancomycin Dry Powder Aerosol to Intubated Rabbits. Molecular Pharmaceutics. PMID 25915095 DOI: 10.1021/acs.molpharmaceut.5b00062  0.68
2015 El-Gendy N, Qian J, Eshelman K, Rivera M, Berkland C. Antibiotic activity of iron-sequestering polymers. Biomacromolecules. 16: 1480-8. PMID 25872681 DOI: 10.1021/bm5016392  0.68
2015 Alhakamy NA, Elandaloussi I, Ghazvini S, Berkland CJ, Dhar P. Effect of lipid headgroup charge and pH on the stability and membrane insertion potential of calcium condensed gene complexes. Langmuir : the Acs Journal of Surfaces and Colloids. 31: 4232-45. PMID 25768428 DOI: 10.1021/la504970n  0.68
2015 Fang WB, Yao M, Jokar I, Alhakamy N, Berkland C, Chen J, Brantley-Sieders D, Cheng N. The CCL2 chemokine is a negative regulator of autophagy and necrosis in luminal B breast cancer cells. Breast Cancer Research and Treatment. 150: 309-20. PMID 25744294 DOI: 10.1007/s10549-015-3324-4  0.68
2015 Beck EC, Lohman BL, Tabakh DB, Kieweg SL, Gehrke SH, Berkland CJ, Detamore MS. Enabling Surgical Placement of Hydrogels Through Achieving Paste-Like Rheological Behavior in Hydrogel Precursor Solutions. Annals of Biomedical Engineering. PMID 25691398 DOI: 10.1007/s10439-015-1277-8  0.68
2015 Pornputtapitak W, El-Gendy N, Berkland C. NanoCluster Itraconazole Formulations Provide a Potential Engineered Drug Particle Approach to Generate Effective Dry Powder Aerosols. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 28: 341-52. PMID 25679514 DOI: 10.1089/jamp.2014.1155  0.68
2015 Hartwell BL, Antunez L, Sullivan BP, Thati S, Sestak JO, Berkland C. Multivalent nanomaterials: learning from vaccines and progressing to antigen-specific immunotherapies. Journal of Pharmaceutical Sciences. 104: 346-61. PMID 25447598 DOI: 10.1002/jps.24273  0.68
2015 Thati S, Kuehl C, Hartwell B, Sestak J, Siahaan T, Forrest ML, Berkland C. Routes of administration and dose optimization of soluble antigen arrays in mice with experimental autoimmune encephalomyelitis. Journal of Pharmaceutical Sciences. 104: 714-21. PMID 25447242 DOI: 10.1002/jps.24272  0.68
2015 Dennis SC, Berkland CJ, Bonewald LF, Detamore MS. Endochondral ossification for enhancing bone regeneration: converging native extracellular matrix biomaterials and developmental engineering in vivo. Tissue Engineering. Part B, Reviews. 21: 247-66. PMID 25336144 DOI: 10.1089/ten.TEB.2014.0419  0.68
2015 Qian J, Berkland C. PH-sensitive triblock copolymers for efficient siRNA encapsulation and delivery Polymer Chemistry. 6: 3472-3479. DOI: 10.1039/c5py00219b  0.68
2014 Sestak JO, Sullivan BP, Thati S, Northrup L, Hartwell B, Antunez L, Forrest ML, Vines CM, Siahaan TJ, Berkland C. Codelivery of antigen and an immune cell adhesion inhibitor is necessary for efficacy of soluble antigen arrays in experimental autoimmune encephalomyelitis. Molecular Therapy. Methods & Clinical Development. 1: 14008. PMID 26015953 DOI: 10.1038/mtm.2014.8  0.68
2014 Northrup L, Sestak JO, Sullivan BP, Thati S, Hartwell BL, Siahaan TJ, Vines CM, Berkland C. Co-delivery of autoantigen and b7 pathway modulators suppresses experimental autoimmune encephalomyelitis. The Aaps Journal. 16: 1204-13. PMID 25297853 DOI: 10.1208/s12248-014-9671-y  0.68
2014 Sestak JO, Fakhari A, Badawi AH, Siahaan TJ, Berkland C. Structure, size, and solubility of antigen arrays determines efficacy in experimental autoimmune encephalomyelitis. The Aaps Journal. 16: 1185-93. PMID 25193268 DOI: 10.1208/s12248-014-9654-z  0.68
2014 Kuehl C, El-Gendy N, Berkland C. NanoClusters surface area allows nanoparticle dissolution with microparticle properties. Journal of Pharmaceutical Sciences. 103: 1787-98. PMID 24788354 DOI: 10.1002/jps.23980  0.68
2014 Dennis SC, Detamore MS, Kieweg SL, Berkland CJ. Mapping glycosaminoglycan-hydroxyapatite colloidal gels as potential tissue defect fillers. Langmuir : the Acs Journal of Surfaces and Colloids. 30: 3528-37. PMID 24606047 DOI: 10.1021/la4041985  0.68
2014 Baoum AA, Middaugh CR, Berkland C. DNA complexed with TAT peptide and condensed using calcium possesses unique structural features compared to PEI polyplexes. International Journal of Pharmaceutics. 465: 11-7. PMID 24508553 DOI: 10.1016/j.ijpharm.2014.01.040  0.68
2014 Pornputtapitak W, El-Gendy N, Mermis J, O'Brien-Ladner A, Berkland C. NanoCluster budesonide formulations enable efficient drug delivery driven by mechanical ventilation. International Journal of Pharmaceutics. 462: 19-28. PMID 24374223 DOI: 10.1016/j.ijpharm.2013.12.030  0.68
2014 Chittasupho C, Sestak J, Shannon L, Siahaan TJ, Vines CM, Berkland C. Hyaluronic acid graft polymers displaying peptide antigen modulate dendritic cell response in vitro. Molecular Pharmaceutics. 11: 367-73. PMID 24283935 DOI: 10.1021/mp4003909  0.68
2014 Fakhari A, Phan Q, Berkland C. Hyaluronic acid colloidal gels as self-assembling elastic biomaterials. Journal of Biomedical Materials Research. Part B, Applied Biomaterials. 102: 612-8. PMID 24124008 DOI: 10.1002/jbm.b.33041  0.68
2013 Alhakamy NA, Kaviratna A, Berkland CJ, Dhar P. Dynamic measurements of membrane insertion potential of synthetic cell penetrating peptides. Langmuir : the Acs Journal of Surfaces and Colloids. 29: 15336-49. PMID 24294979 DOI: 10.1021/la403370p  0.68
2013 El-Gendy N, Kaviratna A, Berkland C, Dhar P. Delivery and performance of surfactant replacement therapies to treat pulmonary disorders. Therapeutic Delivery. 4: 951-80. PMID 23919474 DOI: 10.4155/tde.13.72  0.68
2013 Smaldone G, Berkland C, Gonda I, Mitchell J, Usmani OS, Clark A. Ask the experts: the benefits and challenges of pulmonary drug delivery Therapeutic Delivery. 4: 905-913. PMID 23919470 DOI: 10.4155/tde.13.76  0.68
2013 Dormer NH, Gupta V, Scurto AM, Berkland CJ, Detamore MS. Effect of different sintering methods on bioactivity and release of proteins from PLGA microspheres Materials Science and Engineering C. 33: 4343-4351. PMID 23910352 DOI: 10.1016/j.msec.2013.06.026  0.68
2013 Wang Q, Gu Z, Jamal S, Detamore MS, Berkland C. Hybrid hydroxyapatite nanoparticle colloidal gels are injectable fillers for bone tissue engineering. Tissue Engineering. Part A. 19: 2586-93. PMID 23815275 DOI: 10.1089/ten.TEA.2013.0075  0.68
2013 Alhakamy NA, Nigatu AS, Berkland CJ, Ramsey JD. Noncovalently associated cell-penetrating peptides for gene delivery applications. Therapeutic Delivery. 4: 741-57. PMID 23738670 DOI: 10.4155/tde.13.44  0.68
2013 Sestak J, Mullins M, Northrup L, Thati S, Forrest ML, Siahaan TJ, Berkland C. Single-step grafting of aminooxy-peptides to hyaluronan: a simple approach to multifunctional therapeutics for experimental autoimmune encephalomyelitis. Journal of Controlled Release : Official Journal of the Controlled Release Society. 168: 334-40. PMID 23541930 DOI: 10.1016/j.jconrel.2013.03.015  0.68
2013 Alhakamy NA, Berkland CJ. Polyarginine molecular weight determines transfection efficiency of calcium condensed complexes. Molecular Pharmaceutics. 10: 1940-8. PMID 23534410 DOI: 10.1021/mp3007117  0.68
2013 Fakhari A, Phan Q, Thakkar SV, Middaugh CR, Berkland C. Hyaluronic acid nanoparticles titrate the viscoelastic properties of viscosupplements. Langmuir : the Acs Journal of Surfaces and Colloids. 29: 5123-31. PMID 23514620 DOI: 10.1021/la304575x  0.68
2013 Fakhari A, Berkland C. Applications and emerging trends of hyaluronic acid in tissue engineering, as a dermal filler and in osteoarthritis treatment Acta Biomaterialia. 9: 7081-7092. PMID 23507088 DOI: 10.1016/j.actbio.2013.03.005  0.68
2013 Jeon JH, Bhamidipati M, Sridharan B, Scurto AM, Berkland CJ, Detamore MS. Tailoring of processing parameters for sintering microsphere-based scaffolds with dense-phase carbon dioxide Journal of Biomedical Materials Research - Part B Applied Biomaterials. 101: 330-337. PMID 23115065 DOI: 10.1002/jbm.b.32843  0.68
2013 Beck E, Berkland C, Gehrke S, Detamore M. Novel hyaluronic acid nanocomposite hydrogel for cartilage tissue engineering: Utilizing yield stress for ease of implantation Asme 2013 Summer Bioengineering Conference, Sbc 2013. 1. DOI: 10.1115/SBC2013-14350  0.68
2013 Thaiboonrod S, Berkland C, Milani AH, Ulijn R, Saunders BR. Poly(vinylamine) microgels: PH-responsive particles with high primary amine contents Soft Matter. 9: 3920-3930. DOI: 10.1039/c3sm27728c  0.68
2013 Suekama TC, Aziz V, Mohammadi Z, Berkland C, Gehrke SH. Synthesis and characterization of poly(N-vinyl formamide) hydrogels - A potential alternative to polyacrylamide hydrogels Journal of Polymer Science, Part a: Polymer Chemistry. 51: 435-445. DOI: 10.1002/pola.26401  0.68
2012 El-Gendy N, Selvam P, Soni P, Berkland C. Development of budesonide nanocluster dry powder aerosols: preformulation. Journal of Pharmaceutical Sciences. 101: 3434-44. PMID 22623018 DOI: 10.1002/jps.23197  0.68
2012 El-Gendy N, Huang S, Selvam P, Soni P, Berkland C. Development of budesonide nanocluster dry powder aerosols: formulation and stability. Journal of Pharmaceutical Sciences. 101: 3445-55. PMID 22619045 DOI: 10.1002/jps.23176  0.68
2012 Yang J, Xie SX, Huang Y, Ling M, Liu J, Ran Y, Wang Y, Thrasher JB, Berkland C, Li B. Prostate-targeted biodegradable nanoparticles loaded with androgen receptor silencing constructs eradicate xenograft tumors in mice. Nanomedicine (London, England). 7: 1297-309. PMID 22583574 DOI: 10.2217/nnm.12.14  0.68
2012 Bagby TR, Duan S, Cai S, Yang Q, Thati S, Berkland C, Aires DJ, Forrest ML. Lymphatic trafficking kinetics and near-infrared imaging using star polymer architectures with controlled anionic character. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 47: 287-94. PMID 22546180 DOI: 10.1016/j.ejps.2012.04.016  0.68
2012 El-Gendy N, Selvam P, Soni P, Berkland C. Development of budesonide nanocluster dry powder aerosols: processing. Journal of Pharmaceutical Sciences. 101: 3425-33. PMID 22539360 DOI: 10.1002/jps.23168  0.68
2012 Kawabata A, Baoum A, Ohta N, Jacquez S, Seo GM, Berkland C, Tamura M. Intratracheal administration of a nanoparticle-based therapy with the angiotensin II type 2 receptor gene attenuates lung cancer growth. Cancer Research. 72: 2057-67. PMID 22389453 DOI: 10.1158/0008-5472.CAN-11-3634  0.68
2012 Büyüktimkin B, Wang Q, Kiptoo P, Stewart JM, Berkland C, Siahaan TJ. Vaccine-like controlled-release delivery of an immunomodulating peptide to treat experimental autoimmune encephalomyelitis. Molecular Pharmaceutics. 9: 979-85. PMID 22375937 DOI: 10.1021/mp200614q  0.68
2012 Pornputtapitak W, El-Gendy N, Berkland C. Nanocluster budesonide formulations enhance drug delivery through endotracheal tubes. Journal of Pharmaceutical Sciences. 101: 1063-72. PMID 22095757 DOI: 10.1002/jps.22818  0.68
2012 Dormer NH, Singh M, Zhao L, Mohan N, Berkland CJ, Detamore MS. Osteochondral interface regeneration of the rabbit knee with macroscopic gradients of bioactive signals. Journal of Biomedical Materials Research. Part A. 100: 162-70. PMID 22009693 DOI: 10.1002/jbm.a.33225  0.68
2012 Dormer NH, Qiu Y, Lydick AM, Allen ND, Mohan N, Berkland CJ, Detamore MS. Osteogenic differentiation of human bone marrow stromal cells in hydroxyapatite-loaded microsphere-based scaffolds. Tissue Engineering. Part A. 18: 757-67. PMID 21992088 DOI: 10.1089/ten.TEA.2011.0176  0.68
2012 Baoum A, Ovcharenko D, Berkland C. Calcium condensed cell penetrating peptide complexes offer highly efficient, low toxicity gene silencing. International Journal of Pharmaceutics. 427: 134-42. PMID 21856394 DOI: 10.1016/j.ijpharm.2011.08.012  0.68
2012 Shang Q, Wang X, Apley M, Kukanich SB, Berkland C. PPF microsphere depot sustains NSAID blood levels with infusion-like kinetics without 'burst' Journal of Veterinary Pharmacology and Therapeutics. 35: 231-238. PMID 21696401 DOI: 10.1111/j.1365-2885.2011.01317.x  0.68
2012 Phongpradist R, Chittasupho C, Intasai N, Siahaan TJ, Berkland CJ, Charoenkwan P, Anuchapreeda S, Ampasavate C. Biodegradable nanoparticles surface modification techniques with cIBR peptide targeting to LFA-1 expressing leukemic cells Journal of Nanotechnology in Engineering and Medicine. 3. DOI: 10.1115/1.4023896  0.68
2012 Bailey MM, Kline SR, Anderson MD, Staymates JL, Berkland C. Chemically modifiable fluorinated copolymer nanoparticles for 19F-MRI contrast enhancement Journal of Applied Polymer Science. 126: 1218-1227. DOI: 10.1002/app.36889  0.68
2011 Chittasupho C, Siahaan TJ, Vines CM, Berkland C. Autoimmune therapies targeting costimulation and emerging trends in multivalent therapeutics. Therapeutic Delivery. 2: 873-89. PMID 21984960 DOI: 10.4155/tde.11.60  0.68
2011 El-Gendy N, Pornputtapitak W, Berkland C. Nanoparticle agglomerates of fluticasone propionate in combination with albuterol sulfate as dry powder aerosols. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 44: 522-33. PMID 21964203 DOI: 10.1016/j.ejps.2011.09.014  0.68
2011 Khondee S, Olsen CM, Zeng Y, Middaugh CR, Berkland C. Noncovalent PEGylation by polyanion complexation as a means to stabilize keratinocyte growth factor-2 (KGF-2). Biomacromolecules. 12: 3880-94. PMID 21954860 DOI: 10.1021/bm2007967  0.68
2011 Mohan N, Dormer NH, Caldwell KL, Key VH, Berkland CJ, Detamore MS. Continuous gradients of material composition and growth factors for effective regeneration of the osteochondral interface. Tissue Engineering. Part A. 17: 2845-55. PMID 21815822 DOI: 10.1089/ten.tea.2011.0135  0.68
2011 Lazebnik M, Singh M, Glatt P, Friis LA, Berkland CJ, Detamore MS. Biomimetic method for combining the nucleus pulposus and annulus fibrosus for intervertebral disc tissue engineering. Journal of Tissue Engineering and Regenerative Medicine. 5: e179-87. PMID 21774081 DOI: 10.1002/term.412  0.68
2011 Khondee S, Baoum A, Siahaan TJ, Berkland C. Calcium condensed LABL-TAT complexes effectively target gene delivery to ICAM-1 expressing cells. Molecular Pharmaceutics. 8: 788-98. PMID 21473630 DOI: 10.1021/mp100393j  0.68
2011 Dormer NH, Busaidy K, Berkland CJ, Detamore MS. Osteochondral interface regeneration of rabbit mandibular condyle with bioactive signal gradients. Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons. 69: e50-7. PMID 21470747 DOI: 10.1016/j.joms.2010.12.049  0.68
2011 Chittasupho C, Shannon L, Siahaan TJ, Vines CM, Berkland C. Nanoparticles targeting dendritic cell surface molecules effectively block T cell conjugation and shift response. Acs Nano. 5: 1693-702. PMID 21375342 DOI: 10.1021/nn102159g  0.68
2011 Baoum AA, Berkland C. Calcium condensation of DNA complexed with cell-penetrating peptides offers efficient, noncytotoxic gene delivery. Journal of Pharmaceutical Sciences. 100: 1637-42. PMID 21374602 DOI: 10.1002/jps.22407  0.68
2011 Wang Q, Jamal S, Detamore MS, Berkland C. PLGA-chitosan/PLGA-alginate nanoparticle blends as biodegradable colloidal gels for seeding human umbilical cord mesenchymal stem cells. Journal of Biomedical Materials Research. Part A. 96: 520-7. PMID 21254383 DOI: 10.1002/jbm.a.33000  0.68
2011 Fakhari A, Baoum A, Siahaan TJ, Le KB, Berkland C. Controlling ligand surface density optimizes nanoparticle binding to ICAM-1. Journal of Pharmaceutical Sciences. 100: 1045-56. PMID 20922813 DOI: 10.1002/jps.22342  0.68
2011 Mohammadi Z, Xie SX, Peltier E, Veisi M, Berkland C. Enhancing the selectivity of an iron binding hydrogel European Polymer Journal. 47: 1485-1488. DOI: 10.1016/j.eurpolymj.2011.04.007  0.68
2011 Mohammadi Z, Xie SX, Golub AL, Gehrke SH, Berkland C. Siderophore-mimetic hydrogel for iron chelation therapy Journal of Applied Polymer Science. 121: 1384-1392. DOI: 10.1002/app.33562  0.68
2010 Bailey MM, Berkland C. Therapeutic Particles and Biomaterials Technology Laboratory at the University of Kansas. Therapeutic Delivery. 1: 29-35. PMID 22816117 DOI: 10.4155/tde.10.15  0.68
2010 Bailey MM, Mahoney CM, Dempah KE, Davis JM, Becker ML, Khondee S, Munson EJ, Berkland C. Fluorinated copolymer nanoparticles for multimodal imaging applications. Macromolecular Rapid Communications. 31: 87-92. PMID 21590842 DOI: 10.1002/marc.200900505  0.68
2010 Williams SJ, Huang HH, Kover K, Moore W, Berkland C, Singh M, Smirnova IV, MacGregor R, Stehno-Bittel L. Reduction of diffusion barriers in isolated rat islets improves survival, but not insulin secretion or transplantation outcome. Organogenesis. 6: 115-24. PMID 20885858  0.68
2010 Phongpradist R, Chittasupho C, Okonogi S, Siahaan T, Anuchapreeda S, Ampasavate C, Berkland C. LFA-1 on leukemic cells as a target for therapy or drug delivery. Current Pharmaceutical Design. 16: 2321-30. PMID 20618153 DOI: 10.2174/138161210791920450  0.68
2010 Aillon KL, El-Gendy N, Dennis C, Norenberg JP, McDonald J, Berkland C. Iodinated NanoClusters as an inhaled computed tomography contrast agent for lung visualization. Molecular Pharmaceutics. 7: 1274-82. PMID 20575527 DOI: 10.1021/mp1000718  0.68
2010 Dormer NH, Berkland CJ, Detamore MS. Emerging techniques in stratified designs and continuous gradients for tissue engineering of interfaces. Annals of Biomedical Engineering. 38: 2121-41. PMID 20411333 DOI: 10.1007/s10439-010-0033-3  0.68
2010 Dormer NH, Singh M, Wang L, Berkland CJ, Detamore MS. Osteochondral interface tissue engineering using macroscopic gradients of bioactive signals. Annals of Biomedical Engineering. 38: 2167-82. PMID 20379780 DOI: 10.1007/s10439-010-0028-0  0.68
2010 Xie Y, Aillon KL, Cai S, Christian JM, Davies NM, Berkland CJ, Forrest ML. Pulmonary delivery of cisplatin-hyaluronan conjugates via endotracheal instillation for the treatment of lung cancer. International Journal of Pharmaceutics. 392: 156-63. PMID 20363303 DOI: 10.1016/j.ijpharm.2010.03.058  0.68
2010 Singh M, Dormer N, Salash JR, Christian JM, Moore DS, Berkland C, Detamore MS. Three-dimensional macroscopic scaffolds with a gradient in stiffness for functional regeneration of interfacial tissues. Journal of Biomedical Materials Research. Part A. 94: 870-6. PMID 20336753 DOI: 10.1002/jbm.a.32765  0.68
2010 Wang Q, Wang J, Lu Q, Detamore MS, Berkland C. Injectable PLGA based colloidal gels for zero-order dexamethasone release in cranial defects. Biomaterials. 31: 4980-6. PMID 20303585 DOI: 10.1016/j.biomaterials.2010.02.052  0.68
2010 El-Gendy N, Aillon KL, Berkland C. Dry powdered aerosols of diatrizoic acid nanoparticle agglomerates as a lung contrast agent. International Journal of Pharmaceutics. 391: 305-12. PMID 20214960 DOI: 10.1016/j.ijpharm.2010.03.009  0.68
2010 Pickel L, Matsuzuka T, Doi C, Ayuzawa R, Maurya DK, Xie SX, Berkland C, Tamura M. Over-expression of angiotensin II type 2 receptor gene induces cell death in lung adenocarcinoma cells. Cancer Biology & Therapy. 9: 277-85. PMID 20026904 DOI: 10.4161/cbt.9.4.10643  0.68
2010 Baoum A, Dhillon N, Buch S, Berkland C. Cationic surface modification of PLG nanoparticles offers sustained gene delivery to pulmonary epithelial cells. Journal of Pharmaceutical Sciences. 99: 2413-22. PMID 19911425 DOI: 10.1002/jps.21994  0.68
2010 Chittasupho C, Manikwar P, Krise JP, Siahaan TJ, Berkland C. cIBR effectively targets nanoparticles to LFA-1 on acute lymphoblastic T cells. Molecular Pharmaceutics. 7: 146-55. PMID 19883077 DOI: 10.1021/mp900185u  0.68
2010 Staymates M, Fletcher R, Staymates J, Gillen G, Berkland C. Production and characterization of polymer microspheres containing trace explosives using precision particle fabrication technology. Journal of Microencapsulation. 27: 426-35. PMID 19860542 DOI: 10.3109/02652040903367335  0.68
2010 Singh M, Sandhu B, Scurto A, Berkland C, Detamore MS. Microsphere-based scaffolds for cartilage tissue engineering: using subcritical CO(2) as a sintering agent. Acta Biomaterialia. 6: 137-43. PMID 19660579 DOI: 10.1016/j.actbio.2009.07.042  0.68
2010 Berkland C. Next steps for pharmaceutical nanotechnology Journal of Pharmaceutical Innovation. 5: 70-71. DOI: 10.1007/s12247-010-9084-0  0.68
2010 El-Gendy N, Desai V, Berkland C. Agglomerates of ciprofloxacin nanoparticles yield fine dry powder aerosols Journal of Pharmaceutical Innovation. 5: 79-87. DOI: 10.1007/s12247-010-9082-2  0.68
2010 Mohammadi Z, Wang X, Berkland C. Magnetic polyvinylamine nanoparticles by in situ precipitation reaction Journal of Polymer Science, Part a: Polymer Chemistry. 48: 991-996. DOI: 10.1002/pola.23847  0.68
2010 Khondee S, Yakovleva T, Berkland C. Low charge polyvinylamine nanogels offer sustained, low-level gene expression Journal of Applied Polymer Science. 118: 1921-1932. DOI: 10.1002/app.32460  0.68
2010 Johnson S, Trejo J, Veisi M, Willhite GP, Liang JT, Berkland C. Effects of divalent cations, seawater, and formation brine on positively charged polyethylenimine/dextran sulfate/ chromium(III) polyelectrolyte complexes and partially hydrolyzed polyacrylamide/chromium(III) gelation Journal of Applied Polymer Science. 115: 1008-1014. DOI: 10.1002/app.31052  0.68
2010 Berkland C, Laurence G, Lermer S, Soni P, Crowley M. An overview of NanoCluster powder formulation technology Pharmaceutical Technology. 34: 72-78.  0.68
2010 Pickel L, Matsuzuka T, Doi C, Ayuzawa R, Maurya DK, Xie SX, Berkland C, Tamura M. Overexpression of angiotensin II type 2 receptor gene induces cell death in lung adenocarcinoma cells Cancer Biology and Therapy. 9: 277-285.  0.68
2009 Baoum A, Xie SX, Fakhari A, Berkland C. "Soft" calcium crosslinks enable highly efficient gene transfection using TAT peptide. Pharmaceutical Research. 26: 2619-29. PMID 19789962 DOI: 10.1007/s11095-009-9976-1  0.68
2009 Nune SK, Gunda P, Thallapally PK, Lin YY, Forrest ML, Berkland CJ. Nanoparticles for biomedical imaging. Expert Opinion On Drug Delivery. 6: 1175-94. PMID 19743894 DOI: 10.1517/17425240903229031  0.68
2009 Chittasupho C, Xie SX, Baoum A, Yakovleva T, Siahaan TJ, Berkland CJ. ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 37: 141-50. PMID 19429421 DOI: 10.1016/j.ejps.2009.02.008  0.68
2009 El-Gendy N, Berkland C. Combination chemotherapeutic dry powder aerosols via controlled nanoparticle agglomeration. Pharmaceutical Research. 26: 1752-63. PMID 19415471 DOI: 10.1007/s11095-009-9886-2  0.68
2009 Aillon KL, Xie Y, El-Gendy N, Berkland CJ, Forrest ML. Effects of nanomaterial physicochemical properties on in vivo toxicity. Advanced Drug Delivery Reviews. 61: 457-66. PMID 19386275 DOI: 10.1016/j.addr.2009.03.010  0.68
2009 Williams SJ, Wang Q, Macgregor RR, Siahaan TJ, Stehno-Bittel L, Berkland C. Adhesion of pancreatic beta cells to biopolymer films. Biopolymers. 91: 676-85. PMID 19353639 DOI: 10.1002/bip.21196  0.68
2009 El-Gendy N, Gorman EM, Munson EJ, Berkland C. Budesonide nanoparticle agglomerates as dry powder aerosols with rapid dissolution. Journal of Pharmaceutical Sciences. 98: 2731-46. PMID 19130469 DOI: 10.1002/jps.21630  0.68
2009 Plumley C, Gorman EM, El-Gendy N, Bybee CR, Munson EJ, Berkland C. Nifedipine nanoparticle agglomeration as a dry powder aerosol formulation strategy. International Journal of Pharmaceutics. 369: 136-43. PMID 19015016 DOI: 10.1016/j.ijpharm.2008.10.016  0.68
2009 Mohammadi Z, Cole A, Berkland CJ. In situ synthesis of iron oxide within Polyvinylamine nanoparticle reactors Journal of Physical Chemistry C. 113: 7652-7658. DOI: 10.1021/jp901036b  0.68
2009 Gehrke SH, Berkland CJ, Detamore MS, Aziz V, Danielson L, DeKosky BJ, Dormer NH, Gilbert WJ, Guan H, Huber PA, Lomakin J, Mohammadi Z, Patel A, Suekama T, Van Kampen E. Improving the mechanical performance of hydrogels by controlling the nanostructure Aiche Annual Meeting, Conference Proceedings 0.68
2008 Bailey MM, Gorman EM, Munson EJ, Berkland C. Pure insulin nanoparticle agglomerates for pulmonary delivery. Langmuir : the Acs Journal of Surfaces and Colloids. 24: 13614-20. PMID 18959432 DOI: 10.1021/la802405p  0.68
2008 Singh M, Berkland C, Detamore MS. Strategies and applications for incorporating physical and chemical signal gradients in tissue engineering. Tissue Engineering. Part B, Reviews. 14: 341-66. PMID 18803499 DOI: 10.1089/ten.teb.2008.0304  0.68
2008 Peek LJ, Roberts L, Berkland C. Poly(D,L-lactide-co-glycolide) nanoparticle agglomerates as carriers in dry powder aerosol formulation of proteins. Langmuir : the Acs Journal of Surfaces and Colloids. 24: 9775-83. PMID 18680321 DOI: 10.1021/la8012014  0.68
2008 Peek LJ, Middaugh CR, Berkland C. Nanotechnology in vaccine delivery. Advanced Drug Delivery Reviews. 60: 915-28. PMID 18325628 DOI: 10.1016/j.addr.2007.05.017  0.68
2008 Zhang N, Chittasupho C, Duangrat C, Siahaan TJ, Berkland C. PLGA nanoparticle--peptide conjugate effectively targets intercellular cell-adhesion molecule-1. Bioconjugate Chemistry. 19: 145-52. PMID 17997512 DOI: 10.1021/bc700227z  0.68
2008 Shi L, Khondee S, Linz TH, Berkland C. Poly(N-vinylformamide) nanogels capable of pH-sensitive protein release Macromolecules. 41: 6546-6554. DOI: 10.1021/ma800812z  0.68
2008 Cordova M, Cheng M, Trejo J, Johnson SJ, Willhite GP, Liang JT, Berkland C. Delayed HPAM gelation via transient sequestration of chromium in polyelectrolyte complex nanoparticles Macromolecules. 41: 4398-4404. DOI: 10.1021/ma800211d  0.68
2008 Wang Q, Wang L, Detamore MS, Berkland C. Biodegradable colloidal gels as moldable tissue engineering scaffolds Advanced Materials. 20: 236-239. DOI: 10.1002/adma.200702099  0.68
2007 Shi L, Berkland C. Acid-Labile Polyvinylamine Micro- and Nanogel Capsules. Macromolecules. 40: 4635-4643. PMID 18797513 DOI: 10.1021/ma070443o  0.68
2007 Shi L, Plumley CJ, Berkland C. Biodegradable nanoparticle flocculates for dry powder aerosol formulation. Langmuir : the Acs Journal of Surfaces and Colloids. 23: 10897-901. PMID 17894513 DOI: 10.1021/la7020098  0.68
2007 Arnold MM, Gorman EM, Schieber LJ, Munson EJ, Berkland C. NanoCipro encapsulation in monodisperse large porous PLGA microparticles. Journal of Controlled Release : Official Journal of the Controlled Release Society. 121: 100-9. PMID 17604870 DOI: 10.1016/j.jconrel.2007.05.039  0.68
2007 Berkland C, Pollauf E, Raman C, Silverman R, Kim K', Pack DW. Macromolecule release from monodisperse PLG microspheres: control of release rates and investigation of release mechanism. Journal of Pharmaceutical Sciences. 96: 1176-91. PMID 17455338 DOI: 10.1002/jps.20948  0.68
2007 Huang M, Vitharana SN, Peek LJ, Coop T, Berkland C. Polyelectrolyte complexes stabilize and controllably release vascular endothelial growth factor. Biomacromolecules. 8: 1607-14. PMID 17428030 DOI: 10.1021/bm061211k  0.68
2007 Berkland C, Pollauf E, Varde N, Pack DW, Kim KK. Monodisperse liquid-filled biodegradable microcapsules. Pharmaceutical Research. 24: 1007-13. PMID 17372691 DOI: 10.1007/s11095-006-9197-9  0.68
2006 Dunehoo AL, Anderson M, Majumdar S, Kobayashi N, Berkland C, Siahaan TJ. Cell adhesion molecules for targeted drug delivery. Journal of Pharmaceutical Sciences. 95: 1856-72. PMID 16850395 DOI: 10.1002/jps.20676  0.68
2006 Shi L, Berkland C. PH-triggered dispersion of nanoparticle clusters Advanced Materials. 18: 2315-2319. DOI: 10.1002/adma.200600610  0.68
2005 Pollauf EJ, Berkland C, Kim KK, Pack DW. In vitro degradation of polyanhydride/polyester core-shell double-wall microspheres. International Journal of Pharmaceutics. 301: 294-303. PMID 16051452 DOI: 10.1016/j.ijpharm.2005.06.004  0.68
2005 Raman C, Berkland C, Kim K, Pack DW. Modeling small-molecule release from PLG microspheres: effects of polymer degradation and nonuniform drug distribution. Journal of Controlled Release : Official Journal of the Controlled Release Society. 103: 149-58. PMID 15773062 DOI: 10.1016/j.jconrel.2004.11.012  0.68
2004 Berkland C, Cox A, Kim K, Pack DW. Three-month, zero-order piroxicam release from monodispersed double-walled microspheres of controlled shell thickness. Journal of Biomedical Materials Research. Part A. 70: 576-84. PMID 15307162 DOI: 10.1002/jbm.a.30114  0.68
2004 Berkland C, Pack DW, Kim KK. Controlling surface nano-structure using flow-limited field-injection electrostatic spraying (FFESS) of poly(D,L-lactide-co-glycolide). Biomaterials. 25: 5649-58. PMID 15159081 DOI: 10.1016/j.biomaterials.2004.01.018  0.68
2004 Berkland C, Pollauf E, Pack DW, Kim K. Uniform double-walled polymer microspheres of controllable shell thickness. Journal of Controlled Release : Official Journal of the Controlled Release Society. 96: 101-11. PMID 15063033 DOI: 10.1016/j.jconrel.2004.01.018  0.68
2004 Berkland C, Kipper MJ, Narasimhan B, Kim K, Pack DW. Microsphere size, precipitation kinetics and drug distribution control drug release from biodegradable polyanhydride microspheres Journal of Controlled Release. 94: 129-141. PMID 14684277 DOI: 10.1016/j.jconrel.2003.09.011  0.68
2003 Berkland C, Kim K, Pack DW. PLG microsphere size controls drug release rate through several competing factors. Pharmaceutical Research. 20: 1055-62. PMID 12880292 DOI: 10.1023/A:1024466407849  0.68
2002 Berkland C, King M, Cox A, Kim K, Pack DW. Precise control of PLG microsphere size provides enhanced control of drug release rate. Journal of Controlled Release : Official Journal of the Controlled Release Society. 82: 137-47. PMID 12106984 DOI: 10.1016/S0168-3659(02)00136-0  0.68
2001 Berkland C, Kim K, Pack DW. Fabrication of PLG microspheres with precisely controlled and monodisperse size distributions Journal of Controlled Release. 73: 59-74. PMID 11337060 DOI: 10.1016/S0168-3659(01)00289-9  0.68
Show low-probability matches.